Investment Advisory

The future of human health is the

most consequential

investment of our time.

GLAdvisors connects science-vetted longevity companies with patient capital from family offices, institutional investors, and high-net-worth individuals who are ready to shape the next era of medicine — and build generational wealth from it.

Apply as an Investor
Submit Your Company

$8T

Longevity economy projected by 2030

$30.7B

Longevity biotech market value, 2026

480+

Vetted clinicians, researchers and investors in the GLA network

65%

Of family offices have no longevity allocation — yet

 

About GLAdvisors
Science is the filter. Access is the edge.
GLAdvisors is the investment advisory and dealmaking arm of the Global Longevity Association — one of the most credible voices at the intersection of longevity science, clinical medicine, and capital markets.
The longevity investment space is crowded with promises and short on scientific rigor. Most investors who want exposure to this sector have no structured way to evaluate what they're looking at. Most founders with real science have no trusted intermediary to open the right doors.
GLAdvisors is that intermediary. We vet every company through a clinical and scientific lens before any introduction is made. We prepare investors with the scientific context to deploy capital with confidence. And we do it from the center of the most active longevity research and clinical community in Florida — backed by NIH-supported studies, a 480+ member professional network, and relationships that span from the U.S. Department of Health and Human Services to the world's leading longevity research institutions.
We are not a fund. We are not a bank. We are the trusted layer between serious capital and credible science — and the ecosystem that the longevity investment market has been missing.
Credentials & Standing
NIH-Supported Research
Active community longevity studies in South Florida measuring gut-brain biomarkers in aging populations
HHS Office on Women's Health
GLA's president is an official U.S. Women's Health Ambassador, recognized at the inaugural National Conference on Women's Health
Wall Street Journal
GLA's president recognized as "a leader in the women's health longevity movement"
Milken Institute · Davos/WEF · JP Morgan
Regular contributor to the highest-level global longevity and health investment conversations
Mar-a-Lago Summit Host
Convener of Florida's most exclusive longevity investor gatherings since 2022
Services
Three ways we create the opportunity.
I.
Investment Matchmaking
We curate a pipeline of early-stage longevity startups across gut-brain health, precision diagnostics, women's longevity medicine, neurodegenerative prevention, AI health technology, and regenerative medicine. Every company is vetted through a clinical and scientific lens before any investor introduction is made. We match patient capital with founders who have earned it — and we stay in the room to make sure the relationship succeeds.
II.
Investor Education & Access
Most family offices and high-net-worth investors interested in longevity don't yet have the scientific framework to evaluate it confidently. We close that gap. Through curated events, science briefings, and direct access to GLA's clinical and research network, our investor members understand what they're deploying capital into — and why it works. Informed investors make better decisions.
III.
Startup Readiness & Capital Access
Longevity founders with world-class science frequently struggle to translate it for the investors who need to fund it. We prepare companies before they enter the room — sharpening the science narrative, positioning the investment thesis, and aligning the ask with the right stage of capital. Then we open the doors.
Who We Serve
Two sides of one ecosystem.
For Investors
Patient capital looking for longevity's next decade.
  • —Family offices with $25M+ AUM seeking alternative asset exposure in a sector with multi-decade tailwinds
  • —High-net-worth individuals with no current longevity allocation and strong interest in the space
  • —Emerging fund managers building longevity-focused or health-tech investment theses
  • —Clinician-investors who understand the science but need structured access to vetted deal flow
  • —Impact-aligned investors drawn to the intersection of health equity, prevention medicine, and financial return
For Companies
Science-driven founders ready to meet serious capital.
  • —Seed to Series B longevity companies with validated science and a clear path to market
  • —Sectors: gut-brain health, precision nutrition, women's longevity, AI diagnostics, neuro-aging, regenerative medicine
  • —Founders who need a credible scientific intermediary to open doors to patient capital
  • —Companies seeking investor-readiness preparation before a formal raise
  • —Longevity brands and platforms looking to access GLA's 480+ member clinical and research network
Ella Davar, RD, CDN
Ella Davar, RD, CDN
President, Global Longevity Association
Our Founder
"I don't pick the winner. I build the room where the right people meet — and I know the science well enough to make sure neither side gets burned."
Ella Davar, RD, CDN, is a globally recognized leader in longevity nutrition, the science of healthy aging, and the clinical application of gut-brain medicine. As President of the Global Longevity Association and Founder of the Gut-Brain Method™, she has spent decades at the intersection of clinical nutrition, precision medicine, and longevity research — before that intersection had a name in mainstream science.
Ella brings a rigorous scientific filter to every investment introduction she makes. She has convened GLA's annual Mar-a-Lago summits since 2022, contributes to national health policy through her role as an official HHS Office on Women's Health Ambassador, and is actively conducting NIH-supported community longevity research in South Florida — making her one of the few advisors in this space who is simultaneously building the science and the ecosystem around it.
Her clinical background spans precision nutrition, gut microbiome science, hormonal aging, metabolic health, and disease prevention — giving GLAdvisors a scientific vetting capacity that no purely financial advisory firm can replicate.
WSJ Recognized
HHS Women's Health Ambassador
NIH Research
Milken Institute
Davos / WEF
JP Morgan Panelist
Mar-a-Lago Host
NYU Trained RD, CDN
GLA Membership
Join the network shaping the longevity economy.
Annual GLA membership gives you access to GLAdvisors deal flow, invitation-only investor events, clinical research briefings, CE-accredited longevity education, and the most curated longevity professional network in the world. Membership is the entry point into everything GLA and GLAdvisors offers.
Become a Member →
globallongevityassociation.org
Get in Touch
Ready to enter the ecosystem?
Whether you are an investor making your first move into longevity, a founder preparing for a capital raise, a healthcare institution exploring a research partnership, or a professional who wants to be in the room — every relationship in GLAdvisors begins with a conversation. We respond to every inquiry personally and within 48 hours.
Email
info@globallongevityassociation.org
Website
globallongevityassociation.org
Headquarters
Miami Beach, Florida
Next Event
November 18, 2026
Longevity Investors Summit · Mar-a-Lago, Palm Beach
Ready to Start the Conversation?
Tell us a bit about yourself and what you're looking for — whether that's an introduction, an invitation, or an application. It takes two minutes.
Get in Touch →
Or reach us directly at info@globallongevityassociation.org
We respond within 48 hours.

Longevity is no longer a single discipline. It is a systems challenge—spanning healthcare, economics, policy, capital markets, media, and culture.

The Global Longevity Association (GLA) functions as a global integration network—connecting longevity science with the institutions that shape how societies age. Our role is to translate validated research into standards, strategies, and scalable implementation across industries.

GLA does not promote trends. We professionalize longevity.

What Makes the GLA Network Powerful

GLA operates as a credibility engine and connective infrastructure for the longevity economy:

  • A standards-driven membership network
  • A certification and vetting authority
  • A deal-flow and intelligence hub
  • A policy-adjacent convener

This allows longevity science to move from laboratories and clinics into capital allocation, regulation, education, and public adoption—with rigor and integrity.

Integrated Longevity Across Key Sectors

Media and Education:

  • Role: Shape public understanding, professional education, and cultural narratives around healthspan.
  • GLA Integration:
    GLA collaborates with media leaders, educators, and institutions to elevate evidence-based longevity science—moving the conversation from lifespan to functional, cognitive, and metabolic longevity.

    Impact: Creates informed populations, trained professionals, and future-ready curricula grounded in science—not wellness trends.

Entertainment & Cultural Influence:

  • Role: Influence behavior, identity, and social norms at scale.
  • GLA Integration:
    GLA engages cultural leaders, public figures, and content platforms to responsibly integrate longevity narratives around purpose, mental resilience, social connection, and vitality.

    Impact: Accelerates adoption of healthy behaviors through culture—without diluting scientific credibility.

Public Policy & Governance

  • Role: Address aging at the population, economic, and systems level.
  • GLA Integration:
    GLA serves as a bridge between longevity science and policymakers—advancing prevention-first frameworks, women’s health priorities, and healthspan-driven public policy.

    Impact: Improves long-term healthcare outcomes while reducing the economic burden of chronic disease and unhealthy aging.

Investment & Capital Allocation:

  • Role: Fund innovation and scale solutions that extend healthspan.

  • GLA Integration:
    Through its network, GLA curates de-risked longevity opportunities—including diagnostics, women’s health, gut-brain science, prevention technologies, and infrastructure platforms.

    Impact: Accelerates capital flow into validated, high-integrity longevity solutions—bridging science, enterprise value, and societal impact.

Business, Finance & Enterprise:

  • Role: Operationalize longevity through products, services, and workplace systems.

  • GLA Integration:
    GLA works with founders, executives, and institutions to integrate longevity standards into business models, employee health strategies, and consumer offerings.

    Impact: Creates healthier organizations, more productive workforces, and enterprises aligned with long-term human performance and sustainability.

GLA’s Strategic Position

GLA is not an event series.
It is not a think tank.
It is not a wellness community.

GLA is a global longevity integration platform—aligning science, standards, capital, and policy to address the most pressing challenge of the 21st century: unhealthy aging.

Join the Network Shaping the Longevity Economy

GLA membership provides access to a high-signal, invitation-only network of leaders shaping the future of healthspan across industries.

Empower the future of healthcare.
Shape the systems that define how we live—and age.